Feasibility and safety of Robot Suit HAL treatment for adolescents and adults with cerebral palsy

J Clin Neurosci. 2019 Oct:68:101-104. doi: 10.1016/j.jocn.2019.07.026. Epub 2019 Jul 20.

Abstract

To investigate whether Robot Suit HAL treatment (HAL-T) is safe and feasible for gait disorders in adolescents and adults with cerebral palsy (CP). We tested HAL-T in adolescents and adults with bilateral spastic CP (four men, four women; mean age: 18.2 years). Three participants were classified as level III under the Gross Motor Function Classification System (GMFCS), and five were classified as level IV. The participants underwent HAL-T twice per week for 4 weeks. The outcome measures, which were assessed before and after HAL-T, included comfortable gait speed (CGS), step length (SL), cadence, and GMFCS level. Adverse events were noted. All participants completed the HAL-T sessions despite some mild adverse events occurring. The mean increases in CGS, SL, and cadence were 0.19 ± 0.14 m/s (p = 0.006), 0.09 ± 0.08 m (p = 0.020), and 18.0 ± 15.9 steps/min (p = 0.015), respectively. HAL-T is safe and feasible for gait disorders in patients with CP. HAL-T can significantly improve CGS, SL, and cadence and may be effective for improving walking ability in adolescents and adults with CP.

Keywords: Cerebral palsy; Gait disorders; Robot-assisted gait therapy.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Cerebral Palsy / rehabilitation*
  • Child
  • Exoskeleton Device*
  • Feasibility Studies
  • Female
  • Humans
  • Male
  • Young Adult